Soligenix (SNGX) announced that results from its ricin toxin vaccine development program will be presented next week and are expected to facilitate potential FDA approval.
Of these 7 strategies selected today 6 are Long, bullish in outlook. 1 is Short, bearish in outlook.
While computers can assist with “crunching the numbers”, the decision about when to take Social Security is much more than basic math.
Ekso Bionics (EKSO) sells the first FDA cleared exoskeleton indicated for stroke and spinal cord injury rehabilitation. What was once solely in the realm of science fiction is now science fact.
Commercial selling is beginning to paint a bleak outlook for interest rates.
Franchising needs to be understood if you're going to know whether to invest in a certain business model.
Of these 9 strategies selected today 7 are Long, bullish in outlook. 2 are Short, bearish in outlook.
What really made it possible was "shaking off all failures at a heartbeat!"
"That which we call a rose, by any other word would smell as sweet," said Juliet, implying that Romeo's family name didn't matter to her. But the right name can make a big difference to a corporation.
Probability is high that March 1st was the DOB for the new bear market.